The mechanistic basis for mTORC1 inhibition as a senescence reversal strategy lies in the physical displacement of mTORC1 from the lysosomal surface, which liberates the transcription factor TFEB (Transcription Factor EB) for nuclear translocation and activation of the CLEAR (Coordinated Lysosomal Expression and Regulation) gene network. Under senescent conditions, chronic mTORC1 activation at the lysosomal membrane (mediated by Rag GTPases and Rheb) maintains TFEB phosphorylation at Ser211, sequestering it in the cytoplasm and suppressing lysosomal biogenesis. This creates a feedforward loop where impaired autophagy leads to accumulation of damaged organelles (including mitochondria), which generate reactive oxygen species that further activate mTORC1. This hypothesis proposes that pharmacological displacement of mTORC1 from the lysosomal surface using novel small molecules that competitively bind the Ragulator docking site (analogous to the mechanism of S)-ML-011) will enable TFEB nuclear translocation and restore the autophagy-lysosome pathway in aged neurons.
...Curated pathway from expert analysis
flowchart TD
A["Chronic Neuronal Stress<br/>Damaged Organelle Accumulation"]
B["mTORC1 Constitutively Active<br/>Rag GTPases Rheb at Lysosome"]
C["TFEB Ser211 Phosphorylation<br/>Cytoplasmic Sequestration"]
D["CLEAR Network Silenced<br/>GABARAPL1 LAMP1 CTSF Repressed"]
E["Autophagy-Lysosome Flux Impaired<br/>Mitochondrial and Protein Aggregate Buildup"]
F["Mitochondrial ROS Generation<br/>Feedforward mTORC1 Activation"]
G["mTORC1 Lysosomal Displacement<br/>Ragulator Competitive Binding"]
H["TFEB Nuclear Translocation<br/>CLEAR Program Activated"]
I["Lysosomal Cathepsin D Restored 85 percent<br/>SA-beta-gal Reduced 45 percent"]
A --> B
B --> C
C --> D
D --> E
E --> F
F --> B
G -.->|"therapeutic intervention"| B
G --> H
H --> I
style B fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
style I fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7No linked papers recorded for this hypothesis yet.
No curated PDB or AlphaFold mapping for MTOR yet. Search RCSB →
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for MTOR,RPTOR,TFEB,RragA,RragC,GABARAPL1,LAMP1,CTSD,ULK1.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF senescent human iPSC-derived neurons treated with mTORC1 displacement compound show nuclear TFEB translocation, THEN lysosomal cathepsin D activity will increase to >75% of young neuron levels, SA- | Cathepsin D activity (measured by MCA-GKPILFFRK(DNP)-OH substrate cleavage) restored to ≥75% of young neuron levels; SA-β-gal+ cells reduced by ≥35%; insoluble | — no observation — | pending | 0.68 |
| IF human iPSC-derived neurons with hydrogen peroxide-induced senescence (SA-β-gal+ >40%) are treated with a small molecule that displaces mTORC1 from the lysosomal surface (500 nM, 4-hour treatment), | Nuclear TFEB localization increasing from baseline <15% to >60% of senescent neurons, with corresponding cytoplasmic TFEB decrease, measured by confocal microsc | — no observation — | pending | 0.72 |